[Protection of the liver in anti-mycobacterial treatments].
D000596:Amino Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000009:adverse effects*; D006801:Humans; D008107:Liver Diseases / Q000209:etiology* / Q000517:prevention & control*; D008110:Liver Extracts / Q000627:therapeutic use; D009536:Niacinamide / Q000627:therapeutic use; D009705:Nucleosides / Q000627:therapeutic use; D010713:Phosphatidylcholines / Q000627:therapeutic use; D010743:Phospholipids / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*
D000596:Amino Acids; D000995:Antitubercular Agents; D008110:Liver Extracts; D009705:Nucleosides; D010713:Phosphatidylcholines; D010743:Phospholipids; D009536:Niacinamide; D011736:Pyridoxine
La protezione del fegato nel corso dei trattamenti antimicobatterici.